Last reviewed · How we verify

Vitamin D Levels measurement using chemiluminescent assay

Ghamra Military Hospital · FDA-approved active Small molecule Quality 2/100

Vitamin D Levels measurement using chemiluminescent assay is a Small molecule drug developed by Ghamra Military Hospital. It is currently FDA-approved.

At a glance

Generic nameVitamin D Levels measurement using chemiluminescent assay
SponsorGhamra Military Hospital
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Vitamin D Levels measurement using chemiluminescent assay

What is Vitamin D Levels measurement using chemiluminescent assay?

Vitamin D Levels measurement using chemiluminescent assay is a Small molecule drug developed by Ghamra Military Hospital.

Who makes Vitamin D Levels measurement using chemiluminescent assay?

Vitamin D Levels measurement using chemiluminescent assay is developed and marketed by Ghamra Military Hospital (see full Ghamra Military Hospital pipeline at /company/ghamra-military-hospital).

What development phase is Vitamin D Levels measurement using chemiluminescent assay in?

Vitamin D Levels measurement using chemiluminescent assay is FDA-approved (marketed).

Related